These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 31451207)

  • 21. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
    N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P
    Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
    O'Byrne PM; FitzGerald JM; Zhong N; Bateman E; Barnes PJ; Keen C; Almqvist G; Pemberton K; Jorup C; Ivanov S; Reddel HK
    Trials; 2017 Jan; 18(1):12. PubMed ID: 28069068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
    JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R
    Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.
    Bateman ED; Harrison TW; Quirce S; Reddel HK; Buhl R; Humbert M; Jenkins CR; Peterson S; Ostlund O; O'Byrne PM; Sears MR; Eriksson GS
    Respir Res; 2011 Apr; 12(1):38. PubMed ID: 21463522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma : A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 27933599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
    Rabe KF; Pizzichini E; Ställberg B; Romero S; Balanzat AM; Atienza T; Lier PA; Jorup C
    Chest; 2006 Feb; 129(2):246-256. PubMed ID: 16478838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.
    McCormack PL; Lyseng-Williamson KA
    Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.
    Jenkins CR; Eriksson G; Bateman ED; Reddel HK; Sears MR; Lindberg M; O'Byrne PM
    BMC Pulm Med; 2017 Apr; 17(1):65. PubMed ID: 28427362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
    Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
    BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
    Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
    Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.